Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Li, Yajuan ^a,b   Yan, Mei ^a   Yang, Jichen ^c   Raman, Indu ^a   Du, Yong ^d   Min, Soyoun ^a   Fang, Xiangdong ^b   Mohan, Chandra ^a,d   Li, Quan Zhen ^a,e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Chinese Academy of Sciences   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

^e WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CHEMOKINE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROGEN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UREA; AUTOANTIBODY; GLUTATHIONE S-TRANSFERASE MU 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL INFILTRATION; CONTROLLED STUDY; GENE; GENE PRODUCT; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GSTM2 GENE; HISTOCHEMISTRY; IMMUNE MEDIATED INJURY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY INJURY; MESENCHYMAL STEM CELL; MOUSE; NICK END LABELING; NONHUMAN; OXIDATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DBA MOUSE; GENE THERAPY; GENETICS; IMMUNOLOGY; MEMBRANOUS GLOMERULONEPHRITIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; OXIDATIVE STRESS;

LENTIVIRUS; MUS;

ANIMALS; AUTOANTIBODIES; GENETIC THERAPY; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS, MEMBRANOUS; GLUTATHIONE TRANSFERASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; OXIDATIVE STRESS;

EID: 84893174358     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt408     Document Type: Article

References (50)

1. Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases. Kambham N, Adv Anat Pathol 2012 19 111 124 10.1097/PAP. 0b013e318248b7a1 22313839
2. Pathogenesis of Goodpasture syndrome: a molecular perspective. Borza DB, Neilson EG, Hudson BG, Semin Nephrol 2003 23 522 531 10.1053/S0270-9295(03) 00131-1 14631560
3. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Suzuki Y, Shirato I, Okumura K, Ravetch JV, Takai T, Tomino Y, Ra C, Kidney Int 1998 54 1166 1174 10.1046/j.1523-1755. 1998.00108.x 9767532
4. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. Little MA, Pusey CD, J Nephrol 2004 17 10 S19 15599880
5. Oxidative stress-inducible protein tyrosine phosphatase in glomerulonephritis. Feng L, Xia Y, Seiffert D, Wilson CB, Kidney Int 1995 48 1920 1928 10.1038/ki.1995.492 8587253
6. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Kanaguchi Y, Suzuki Y, Osaki K, Sugaya T, Horikoshi S, Tomino Y, Nephrol Dial Transplant 2011 26 3465 3473 10.1093/ndt/gfr110 21525165
7. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Ferguson MA, Vaidya VS, Waikar SS, Collings FB, Sunderland KE, Gioules CJ, Bonventre JV, Kidney Int 2010 77 708 714 10.1038/ki.2009.422 19940842
8. Free radicals and antioxidants in normal physiological functions and human disease. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J, Int J Biochem Cell Biol 2007 39 44 84 10.1016/j.biocel.2006.07.001 16978905
9. Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Rehan A, Johnson KJ, Wiggins RC, Kunkel RG, Ward PA, Lab Invest 1984 51 396 403 6090809
10. Oxidants in chronic kidney disease. Shah SV, Baliga R, Rajapurkar M, Fonseca VA, J Am Soc Nephrol 2007 18 16 28 10.1681/ASN.2006050500 17167116
11. RANTES deficiency attenuates autoantibody-induced glomerulonephritis. Xie C, Liu K, Fu Y, Qin X, Jonnala G, Wang T, Wang HW, Maldonado M, Zhou XJ, Mohan C, J Clin Immunol 2011 31 128 135 10.1007/s10875-010-9470-x 20886281
12. Strain distribution pattern of susceptibility to immune-mediated nephritis. Xie C, Sharma R, Wang H, Zhou XJ, Mohan C, J Immunol 2004 172 5047 5055 15067087
13. Reduced expression of GSTM2 and increased oxidative stress in spontaneously hypertensive rat. Zhou SG, Wang P, Pi RB, Gao J, Fu JJ, Fang J, Qin J, Zhang HJ, Li RF, Chen SR, Tang FT, Liu PQ, Mol Cell Biochem 2008 309 99 107 10.1007/s11010-007-9647-7 18008142
14. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ, Circulation 1995 91 2488 2496 10.1161/01.CIR.91.9.2488 7729036
15. A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Hayek T, Stephens JW, Hubbart CS, Acharya J, Caslake MJ, Hawe E, Miller GJ, Hurel SJ, Humphries SE, Atherosclerosis 2006 184 404 412 10.1016/j.atherosclerosis.2005.05.017 16002077
16. Glutathione S-transferase: genetics and role in toxicology. Strange RC, Jones PW, Fryer AA, Toxicol Lett 2000 112-113 357 363
17. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sanchez E, Kelly JA, Li L, Liu Y, Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de Ramon E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson GG, Kimberly RP, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, et al. J Clin Invest 2009 119 911 923 10.1172/JCI36728 19307730
18. The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis. Li QZ, Zhou J, Yang R, Yan M, Ye Q, Liu K, Liu S, Shao X, Li L, Zhou XJ, Wakeland EK, Mohan C, Genes Immun 2009 10 503 508 10.1038/gene.2009.7 19262577
19. Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice. Lu H, Zhen J, Wu T, Peng A, Ye T, Wang T, Yu X, Vaziri ND, Mohan C, Zhou XJ, Am J Physiol Renal Physiol 2010 299 445 F452 10.1152/ajprenal.00583.2009 20504883
20. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Zhou XJ, Laszik Z, Wang XQ, Silva FG, Vaziri ND, Lab Invest 2000 80 1905 1914 10.1038/labinvest.3780200 11140702
21. Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Paust HJ, Turner JE, Riedel JH, Disteldorf E, Peters A, Schmidt T, Krebs C, Velden J, Mittrucker HW, Steinmetz OM, Stahl RA, Panzer U, Kidney Int 2012 82 72 83 10.1038/ki.2012.101 22495297
22. Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. Sheryanna A, Bhangal G, McDaid J, Smith J, Manning A, Foxwell BM, Feldmann M, Cook HT, Pusey CD, Tam FW, J Am Soc Nephrol 2007 18 1167 1179 10.1681/ASN.2006010050 17314328
23. Lupus nephritis: an overview of recent findings. de Zubiria Salgado A, Herrera-Diaz C, Autoimmune Dis 2012 2012 849684 22536486
24. Human dendritic cells induce the differentiation of interleukin-21- producing T follicular helper-like cells through interleukin-12. Schmitt N, Morita R, Bourdery L, Bentebibel SE, Zurawski SM, Banchereau J, Ueno H, Immunity 2009 31 158 169 10.1016/j.immuni.2009.04.016 19592276
25. Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F, Autoimmun Rev 2005 4 542 548 10.1016/j.autrev.2005.04.009 16214093
26. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Shah D, Wanchu A, Bhatnagar A, Immunobiology 2011 216 1010 1017 10.1016/j.imbio.2011.04.001 21601309
27. Autoimmunity and oxidatively modified autoantigens. Kurien BT, Scofield RH, Autoimmun Rev 2008 7 567 573 10.1016/j.autrev.2008.04.019 18625446
28. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Vaziri ND, Curr Opin Nephrol Hypertens 2004 13 93 99 10.1097/00041552-200401000-00013 15090865
29. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J, Kidney Int 2004 65 1009 1016 10.1111/j.1523-1755.2004.00465.x 14871421
30. Oxidants and iron in chronic kidney disease. Shah SV, Kidney Int Suppl 2004 91 50 S55 15461704
31. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C, Kidney Int 2005 68 1613 1617 10.1111/j.1523-1755.2005.00573.x 16164638
32. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C, Am J Physiol Renal Physiol 2005 289 31 F42 10.1152/ajprenal.00007.2005 15713913
33. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hagiwara M, Shen B, Chao L, Chao J, Hum Gene Ther 2008 19 807 819 10.1089/hum.2008.016 18554097
34. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Vanella L, Kim DH, Asprinio D, Peterson SJ, Barbagallo I, Vanella A, Goldstein D, Ikehara S, Kappas A, Abraham NG, Bone 2010 46 236 243 10.1016/j.bone.2009.10.012 19853072
35. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice. Gao Y, Yao A, Zhang W, Lu S, Yu Y, Deng L, Yin A, Xia Y, Sun B, Wang X, Oncogene 2010 29 2784 2794 10.1038/onc.2010.38 20190814
36. Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress. Li Y, Raman I, Du Y, Yan M, Min S, Yang J, Fang X, Li W, Lu J, Zhou XJ, Mohan C, Li QZ, PLoS One 2013 8 67790 10.1371/journal.pone.0067790 23935844
37. Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis. Shao X, Yang R, Yan M, Li Y, Du Y, Raman I, Zhang B, Wakeland EK, Igarashi P, Mohan C, Li QZ, Arthritis Rheum 2013 65 780 791 10.1002/art.37798 23280471
38. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. Njoku CJ, Patrick KS, Ruiz P Jr, Oates JC, J Investig Med 2005 53 347 352 10.2310/6650.2005.53705 16297360
39. Role of the Anti-Apoptotic Proteins BCL2 and MCL1 in the Neonatal Mouse Ovary. Jones RL, Pepling ME, Biol Reprod 2013 88 46 10.1095/biolreprod.112. 103028 23269665
40. Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array. Jin X, Wu XX, Jin C, Inui M, Sugimoto M, Kakehi Y, Anticancer Drugs 2012 23 445 454 10.1097/CAD.0b013e32834fd796 22205156
41. Evolution of differential substrate specificities in Mu class glutathione transferases probed by DNA shuffling. Hansson LO, Bolton-Grob R, Massoud T, Mannervik B, J Mol Biol 1999 287 265 276 10.1006/jmbi.1999.2607 10080890
42. Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Dusinska M, Staruchova M, Horska A, Smolkova B, Collins A, Bonassi S, Volkovova K, Mutat Res 2012 736 130 137 10.1016/j.mrfmmm.2012.03.003 22450146
43. Redox state, cell death and autoimmune diseases: a gender perspective. Ortona E, Margutti P, Matarrese P, Franconi F, Malorni W, Autoimmun Rev 2008 7 579 584 10.1016/j.autrev.2008.06.001 18599384
44. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Kokoszka JE, Coskun P, Esposito LA, Wallace DC, Proc Natl Acad Sci U S A 2001 98 2278 2283 10.1073/pnas.051627098 11226230
45. Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Miyamoto Y, Koh YH, Park YS, Fujiwara N, Sakiyama H, Misonou Y, Ookawara T, Suzuki K, Honke K, Taniguchi N, Biol Chem 2003 384 567 574 12751786
46. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC, Antioxid Redox Signal 2004 6 289 300 10.1089/152308604322899350 15025930
47. Mechanisms of tissue injury in lupus nephritis. Nowling TK, Gilkeson GS, Arthritis Res Ther 2011 13 250 10.1186/ar3528 22192660
48. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, El-Sorougy IM, Abdou MS, Int J Rheum Dis 2011 14 325 331 10.1111/j.1756-185X.2011.01630.x 22004228
49. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, Hou Y, Zeng X, Gilkeson GS, Sun L, Ann Rheum Dis 2010 69 1423 1429 20650877
50. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Chang JW, Hung SP, Wu HH, Wu WM, Yang AH, Tsai HL, Yang LY, Lee OK, Cell Transplant 2011 20 245 257 10.3727/096368910X520056 20719085